BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy

FDA Regulatory Profile

BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy appears in FDA public data with 3 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0086-2023, Class I) was initiated on December 1, 2022.

Summary

Total Recalls
3 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0086-2023Class IIohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes December 1, 2022
D-0569-2022Class IIINorepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central PFebruary 14, 2022
D-0702-2021Class IISuccinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare CeJuly 30, 2021